Chimeric (ASX:CHM) share price finishes flat on quarterly update

The Chimeric Therapeutics Ltd (ASX: CHM) share price seesawed today following the release of its quarterly update. Here’s the key highlights.
The post Chimeric (ASX:CHM) share price finishes flat on quarterly update appeared first on The Motley Fool Australia. –

woman in lab coat conducting testing representing mesoblast share price

The Chimeric Therapeutics Ltd (ASX: CHM) share price edged higher in the final hour, before falling flat today. This comes despite the company releasing its quarterly update to the ASX towards the latter part of the afternoon.

At the end of today’s market wrap, the biotechnology company’s shares finished the day flat at 28.5 cents.

How did Chimeric perform?

Investors led Chimeric shares to close the day unchanged despite the company recapping its achievements and providing a financial update.

In the release, Chimeric reported a number of highlights, signalling why its shares have surged since listing on the ASX.

Chimeric declared $23.6 million in cash at the end of the March quarter. This is a significant increase from the $65,000 achieved at 31 December 2020. The company noted the funds will be used to progress its clinical trials of CLTX CAR T and begin the development of a cell therapy pipeline.

The net cash used in operating activities stood at $5.4 million, predominately due to the one-off fee paid to the City of Hope. This compares to the $1.9 million recorded in the prior quarter. Most of the fees were allocated towards change of control fee, administrative and corporate costs.

Net cash used in investing activities totalled $2.6 million, which was relatively in line with the December quarter. The payment relates to the second instalment to the City of Hope licence agreement.

The company re-touched on its CLTX CAR T clinical trials, with the second patient cohort now commencing a higher dosing level.

In addition, Chimeric reverted back to its significant management appointments in which several distinguished experts joined the board.

Chimeric share price summary

While the company is still relatively new on the ASX boards, the Chimeric share price moved between the 28 cents and 44 cents range. The company’s shares hit its all-time in the same week of its listing.

On valuation metrics, Chimeric presides a market capitalisation of roughly $56.3 million, with 196.5 million shares on issue.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of February 15th 2021

More reading

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Chimeric (ASX:CHM) share price finishes flat on quarterly update appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!